Compare IRON & DGII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | DGII |
|---|---|---|
| Founded | 2017 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 2020 | 1995 |
| Metric | IRON | DGII |
|---|---|---|
| Price | $80.94 | $73.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $103.18 | $48.80 |
| AVG Volume (30 Days) | 320.6K | ★ 350.4K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.05 |
| EPS | N/A | ★ 1.00 |
| Revenue | N/A | ★ $430,221,000.00 |
| Revenue This Year | N/A | $18.71 |
| Revenue Next Year | $283.52 | $7.22 |
| P/E Ratio | ★ N/A | $74.91 |
| Revenue Growth | N/A | ★ 1.46 |
| 52 Week Low | $40.00 | $33.41 |
| 52 Week High | $99.50 | $86.84 |
| Indicator | IRON | DGII |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 48.54 |
| Support Level | $70.73 | $62.53 |
| Resistance Level | $82.74 | $76.41 |
| Average True Range (ATR) | 2.94 | 3.64 |
| MACD | 0.05 | -1.02 |
| Stochastic Oscillator | 87.72 | 25.79 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.